Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06375044
Title Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Jiangsu Simcere Pharmaceutical Co., Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Dana Farber Cancer institution NOT_YET_RECRUITING Boston Massachusetts 02215 United States Details
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health RECRUITING New York New York 10016 United States Details
Icahn School of Medicine at Mount Sinai,The Tisch Cancer Institute NOT_YET_RECRUITING New York New York 10029 United States Details
Beijing Chaoyang Hospital Capital Medical University RECRUITING Beijing Beijing 100000 China Details
Sun Yat-sen University Cancer Center RECRUITING Guangzhou Guangdong 510000 China Details
Henan Cancer Hospital RECRUITING Zhengzhou Henan 450000 China Details
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences RECRUITING Tianjin Tianjin 300000 China Details
The First Affiliated Hospital Zhejiang University School of Medicine RECRUITING Hanzhou Zhejiang 310000 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field